I may be wrong but I recall both CSL and Baxter had no luck with this some years ago. Not sure if the treatment method was the same though, but yes if it works then demand for blood products will benefit CSL
https://www.fnarena.com/index.php/2013/05/10/csl-analysts-shrug-off-alzheimers-disappointment/
CSL has more upside..., page-3
Add CSL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$275.80 |
Change
0.410(0.15%) |
Mkt cap ! $133.2B | |||
| Open | High | Low | Value | Volume |
| $276.00 | $277.50 | $274.44 | $131.0M | 472.2K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 83 | $275.78 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $275.93 | 109 | 1 |
View Market Depth
| Last trade - 16.10pm 03/05/2024 (20 minute delay) ? |
|
|||||
|
Last
$276.25 |
Change
0.410 ( 0.14 %) |
||||
| Open | High | Low | Volume | ||
| $276.01 | $277.50 | $274.48 | 149758 | ||
| Last updated 15.59pm 03/05/2024 ? | |||||
| CSL (ASX) Chart |